Quantitative auxiliary-free chirality sensing with a metal probe
11860084 ยท 2024-01-02
Assignee
Inventors
- Christian Wolf (Arlington, VA)
- Zeus A. O. DE LOS SANTOS (Washington, DC, US)
- Ciaran LYNCH (Washington, DC, US)
Cpc classification
International classification
Abstract
The present invention relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, and providing a probe selected from the group consisting of metal salts. The sample is contacted with the probe under conditions that permit coordination of the probe to the analyte, if present in the sample; and, based on any coordination that occurs, the absolute configuration of the analyte in the sample, and/or the concentration of the analyte in the sample, and/or the enantiomeric composition of the analyte in the sample is/are determined.
Claims
1. An analytical method comprising: providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms; providing a probe in the form of a ligand-free metal salt; contacting the sample with the probe under conditions that permit coordination of the probe to the analyte, if present in the sample; and determining, based on any coordination that occurs, the absolute configuration of the analyte in the sample, and/or the concentration of the analyte in the sample, and/or the enantiomeric composition of the analyte in the sample.
2. The analytical method of claim 1, wherein the probe is a transition metal salt or lanthanide metal salt selected from the group consisting of ligand-free cobalt salts, ligand-free palladium salts, ligand-free copper salts, ligand-free iron salts, ligand-free manganese salts, ligand-free cerium salts, and ligand-free rhodium salts.
3. The analytical method of claim 2, wherein the ligand-free cobalt salt is selected from the group consisting of Co(NO.sub.3).sub.2, Co(ClO.sub.4).sub.2, Co(OH).sub.2, CoC.sub.2O.sub.4.Math.2H.sub.2O, Co(SCN).sub.2, CoF.sub.2, CoBr.sub.2, CoC.sub.12, CoI.sub.2, Co.sub.3(PO.sub.4).sub.2, CoSO.sub.4, Co(CO.sub.3).sub.2, Co(C.sub.2O.sub.4).sub.2, and their hydrates.
4. The analytical method of claim 2, wherein the ligand-free palladium salt is selected from the group consisting of Pd(NO.sub.3).sub.2, Pd(CN).sub.2, PdF.sub.2, PdBr.sub.2, PdCl.sub.2, PdI.sub.2, PdSO.sub.4, Pd(ACN).sub.2(Br).sub.2, Pd(ACN).sub.4(BF.sub.4).sub.2, Pd(ACN).sub.2Cl.sub.2, and their hydrates.
5. The analytical method of claim 2, wherein the ligand-free copper salt is selected from the group consisting of CuBr, CuBr(Me.sub.2S) complex, CuCl, CuF, CuI, CuSCN, Cu(OAc), Cu(ACN).sub.4PF.sub.6, Cu(ACN).sub.4BF.sub.4, Cu(ACN).sub.4OTf, Cu(NO.sub.3).sub.2, Cu(ClO.sub.4).sub.2, CuSO.sub.4, CuF.sub.2, CuBr.sub.2, CuC.sub.12, CuCl.sub.2.Math.2H.sub.2O, Cu.sub.2(P.sub.2O.sub.7), Cu(tartrate).sub.2, Cu(BF.sub.4).sub.2, Cu(SCN).sub.2, Cu(OAc).sub.2, Cu(acac).sub.2, Cu(CO.sub.3).sub.2, Cu(t-butylacac).sub.2, Cu(OTf).sub.2, and their hydrates.
6. The analytical method of claim 2, wherein the ligand-free iron salt is selected from the group consisting of Fe(NO.sub.3).sub.2, Fe(C.sub.2O.sub.4).sub.2, Fe(ClO.sub.4).sub.2, Fe.sub.3(PO.sub.4).sub.2, Fe(BF.sub.4).sub.2, FeC.sub.2O.sub.4.Math.2H.sub.2O, FeSO.sub.4, FeF.sub.2, FeBr.sub.2, FeCl.sub.2, FeI.sub.2, FeCl.sub.3.Math.6H.sub.2O, FeCl.sub.2.Math.4H.sub.2O, FeF.sub.3, FeBr.sub.3, FeCl.sub.3, Fe(NO.sub.3).sub.3, Fe.sub.2(C.sub.2O.sub.4).sub.3, FePO.sub.4, Fe(acac).sub.3, and their hydrates.
7. The analytical method of claim 2, wherein the ligand-free manganese salt is selected from the group consisting of Mn(CO.sub.3).sub.2, Mn(NO.sub.3).sub.2, MnSO.sub.4.Math.2H.sub.2O, MnF.sub.2, MnBr.sub.2, MnCl.sub.2, MnCl.sub.2.Math.4H.sub.2O, MnI.sub.2, Mn(formate).sub.2, Mn(ClO.sub.4).sub.2, and their hydrates.
8. The analytical method of claim 2, wherein the ligand-free cerium salt is selected from the group consisting of CeBr.sub.3, CeCl.sub.3, CeF.sub.3, Ce(CO.sub.3).sub.3, Ce(OAc).sub.3, Ce(NO.sub.3).sub.3, Ce(acac).sub.3, Ce(C.sub.2O.sub.4).sub.3, Ce(SO.sub.4).sub.3, Ce(NO.sub.3).sub.3.Math.6H.sub.2O, CeCl.sub.3.Math.7H.sub.2O, and their hydrates.
9. The analytical method of claim 2, wherein the ligand-free rhodium salt is selected from the group consisting of Rh(OAc).sub.3, Rh(NO.sub.3).sub.3, RhCl.sub.3.Math.3H.sub.2O, Rh(SO.sub.4).sub.3, and their hydrates.
10. The analytical method of claim 1, wherein the analyte is selected from the group consisting of amines, diamines, amino alcohols, carboxylic acids, hydroxy acids, amino acids, amino phosphonic acids, alcohols, thiols, amides, and combinations thereof.
11. The analytical method of claim 1, wherein said conditions to permit coordination of the probe to the analyte include oxidizing conditions.
12. The analytical method of claim 1 further comprising: addition of a base.
13. The analytical method of claim 1, wherein said contacting is carried out in a solvent selected from aqueous solvents, protic solvents, aprotic solvents, and any combination thereof.
14. The analytical method of claim 1, wherein said contacting is carried out under air or in an aqueous environment.
15. The analytical method of claim 1, wherein said contacting is carried out for about 1 to about 300 minutes.
16. The analytical method of claim 1, wherein said contacting is carried out at about 20 C. to about 100 C.
17. The analytical method of claim 1, wherein the absolute configuration of the analyte is determined using circular dichroism spectroscopy, optical rotatory dispersion, or polarimetry.
18. The analytical method of claim 1, wherein the concentration of the analyte is determined using UV/Vis spectroscopy, fluorescence spectroscopy, and/or other spectroscopic techniques.
19. The analytical method of claim 1, wherein the enantiomeric composition of the analyte is determined using circular dichroism spectroscopy, optical rotatory dispersion, or polarimetry.
20. The analytical method of claim 1, wherein the analyte is a reaction product and the stereoselectivity and yield of the reaction are determined by determining the enantiomeric composition and concentration of the analyte.
21. The analytical method of claim 1, wherein the metal is a non-fluorescent metal ion.
22. The analytical method of claim 21, wherein said determining further comprises using emission spectroscopy.
23. The analytical method of claim 1, wherein said determining comprises using absorption spectroscopy and/or transmission spectroscopy.
24. The analytical method of claim 1, wherein said determining is carried out using circular dichroism spectroscopy and the metal produces circular dichroism signals at a high wavelength and/or at a high intensity.
25. The analytical method of claim 1, wherein the analyte:metal molar ratio is about 1:1, about 2:1, about 3:1, about 4:1, about 5:1, or about 6:1.
26. The analytical method of claim 1, wherein the method is carried out in the absence of an auxiliary ligand or group, in the absence of a chromophore ligand, in the absence of an organic ligand, or in the absence of both a chromophore ligand and organic ligand.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)
(41)
(42)
(43)
(44)
(45)
(46)
(47)
(48)
(49)
(50)
(51)
(52)
(53)
(54)
(55)
(56)
(57)
(58)
(59)
(60)
(61)
(62)
(63)
(64)
(65)
(66)
(67)
(68)
(69)
(70)
(71)
(72)
(73)
(74)
(75)
(76)
(77)
(78)
(79)
(80)
(81)
(82)
(83)
(84)
(85)
(86)
(87)
(88)
(89)
(90)
(91)
(92)
(93)
(94)
(95)
(96)
(97)
(98)
(99)
(100)
(101)
(102)
(103)
(104)
(105)
(106)
(107)
(108)
(109)
(110)
(111)
(112)
(113)
(114)
(115)
(116)
(117)
(118)
(119)
(120)
(121)
(122)
(123)
(124)
(125)
(126)
(127)
(128)
(129)
(130)
(131)
(132)
(133)
(134)
(135)
(136)
(137)
(138)
(139)
(140)
(141)
(142)
(143)
(144)
(145)
(146)
(147)
(148)
(149)
(150)
(151)
(152)
DETAILED DESCRIPTION OF THE INVENTION
(153) The present invention relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, and providing a probe selected from the group consisting of metal salts. The sample is contacted with the probe under conditions that permit coordination of the probe to the analyte, if present in the sample; and, based on any coordination that occurs, the absolute configuration of the analyte in the sample, and/or the concentration of the analyte in the sample, and/or the enantiomeric composition of the analyte in the sample is/are determined
(154) The analytical methods described herein may be used to evaluate a wide range of chiral analytes. The analyte is one that can exist in stereoisomeric forms. This includes enantiomers, diastereomers, and a combination thereof. As will be understood, the analyte can be any chiral analyte that can coordinate with a metal. Suitable analytes include, for example, amines, diamines, amino alcohols, carboxylic acids, hydroxy acids, amino acids, amino phosphonic acids, alcohols, thiols, amides, and combinations thereof.
(155) The amino acid analyte can be any natural or non-natural chiral amino acid, including alpha amino acids, beta amino acids, gamma amino acids, L-amino acids, and D-amino acids. In some embodiments, the amino acid comprises a functionalized side chain. In some embodiments, the analyte is an unprotected amino acid.
(156) Any metal salt may be used for the probes of the present invention. As will be apparent to the skilled artisan, some metals have more than one oxidation state, which may have different spectral profiles. Thus, when using such metals, it is preferable to use metal ions of the same oxidation state. Alternatively, a known mixture could be used, provided one is able to properly interpret any spectral changes that may occur after the sample is added. Exemplary metals salts according to all aspects of the present invention include, without limitation, transition metal (e.g., type II transition metal) salts and lanthanide metal salts. Suitable metal salts include, for example, cobalt salts, palladium salts, copper salts, iron salts, manganese salts, cerium salts, and rhodium salts. Exemplary cobalt salts include, but are not limited to, Co(NO.sub.3).sub.2, Co(ClO.sub.4).sub.2, Co(OH).sub.2, CoC.sub.2O.sub.4.Math.2H.sub.2O, Co(SCN).sub.2, CoF.sub.2, CoBr.sub.2, CoCl.sub.2, CoI.sub.2, Co.sub.3(PO.sub.4).sub.2, CoSO.sub.4, Co(CO.sub.3).sub.2, Co(C.sub.2O.sub.4).sub.2, and their hydrates. Exemplary palladium salts include, but are not limited to, Pd(NO.sub.3).sub.2, Pd(CN).sub.2, PdF.sub.2, PdBr.sub.2, PdCl.sub.2, PdI.sub.2, PdSO.sub.4, Pd(ACN).sub.2(Br).sub.2, Pd(ACN).sub.4(BF.sub.4).sub.2, Pd(ACN).sub.2Cl.sub.2, and their hydrates. Exemplary copper salts include, but are not limited to, CuBr, CuBr(Me.sub.2S) complex, CuCl, CuF, CuI, CuSCN, Cu(OAc), Cu(ACN).sub.4PF.sub.6, Cu(ACN).sub.4BF.sub.4, Cu(ACN).sub.4OTf, Cu(NO.sub.3).sub.2, Cu(ClO.sub.4).sub.2, CuSO.sub.4, CuF.sub.2, CuBr.sub.2, CuCl.sub.2, CuCl.sub.2.Math.2H.sub.2O, Cu.sub.2(P.sub.2O.sub.7), Cu(tartrate).sub.2, Cu(BF.sub.4).sub.2, Cu(SCN).sub.2, Cu(OAc).sub.2, Cu(acac).sub.2, Cu(CO.sub.3).sub.2, Cu(t-butylacac).sub.2, Cu(OTf).sub.2, and their hydrates. Exemplary iron salts include, but are not limited to, Fe(NO.sub.3).sub.2, Fe(C.sub.2O.sub.4).sub.2, Fe(ClO.sub.4).sub.2, Fe.sub.3(PO.sub.4).sub.2, Fe(BF.sub.4).sub.2, FeC.sub.2O.sub.4.Math.2H.sub.2O, FeSO.sub.4, FeF.sub.2, FeBr.sub.2, FeCl.sub.2, FeI.sub.2, FeCl.sub.3.Math.6H.sub.2O, FeCl.sub.2.Math.4H.sub.2O, FeF.sub.3, FeBr.sub.3, FeCl.sub.3, Fe(NO.sub.3).sub.3, Fe.sub.2(C.sub.2O.sub.4).sub.3, FePO.sub.4, Fe(acac).sub.3, and their hydrates. Exemplary manganese salts include, but are not limited to, Mn(CO.sub.3).sub.2, Mn(NO.sub.3).sub.2, MnSO.sub.4.Math.2H.sub.2O, MnF.sub.2, MnBr.sub.2, MnCl.sub.2, MnCl.sub.2.Math.4H.sub.2O, MnI.sub.2, Mn(formate).sub.2, Mn(ClO.sub.4).sub.2, and their hydrates. Exemplary cerium salts include, but are not limited to, CeBr.sub.3, CeCl.sub.3, CeF.sub.3, Ce(CO.sub.3).sub.3, Ce(OAC).sub.3, Ce(NO.sub.3).sub.3, Ce(aCaC).sub.3, Ce(C.sub.2O.sub.4).sub.3, Ce(SO.sub.4).sub.3, Ce(NO.sub.3).sub.3.Math.6H.sub.2O, CeCl.sub.3.Math.7H.sub.2O, and their hydrates. Exemplary rhodium salts include, but are not limited to, Rh(OAc).sub.3, Rh(NO.sub.3).sub.3, RhCl.sub.3.Math.3H2O, Rh(SO4)3, and their hydrates. In certain embodiments, the metal is a non-fluorescent metal ion.
(157) The term hydrate includes but is not limited to hemihydrate, monohydrate, dihydrate, trihydrate and the like.
(158) In certain embodiments, the determining step is carried out using circular dichroism spectroscopy and the metal produces circular dichroism signals at a high wavelength (e.g., at least above about 300 nm; e.g., at least about 300 to at least about 400 nm) and/or at a high intensity (e.g., at least above about 10 mDeg/mMol; e.g., at least about 10 mDeg/mMol to at least about 500 mDeg/mMol; e.g., at least in a range with a lower limit of about 10 mDeg/mMol, about 40 mDeg/mMol, about 70 mDeg/mMol, about 100 mDeg/mMol, about 130 mDeg/mMol, about 160 mDeg/mMol, about 190 mDeg/mMol, about 220 mDeg/mMol, about 250 mDeg/mMol, about 280 mDeg/mMol, about 310 mDeg/mMol, about 340 mDeg/mMol, about 370 mDeg/mMol, about 400 mDeg/mMol, about 430 mDeg/mMol, about 460 mDeg/mMol, or about 490 mDeg/mMol, and an upper limit of about 40 mDeg/mMol, about 70 mDeg/mMol, about 100 mDeg/mMol, about 130 mDeg/mMol, about 160 mDeg/mMol, about 190 mDeg/mMol, about 220 mDeg/mMol, about 250 mDeg/mMol, about 280 mDeg/mMol, about 310 mDeg/mMol, about 340 mDeg/mMol, about 370 mDeg/mMol, about 400 mDeg/mMol, about 430 mDeg/mMol, about 460 mDeg/mMol, about 490 mDeg/mMol, or about 500 mDeg/mMol, or any combination thereof).
(159) As will be apparent to a skilled artisan, any suitable counter anion may be used in the metal salt. Exemplary anions include, but are not limited to, organic anions, inorganic anions, halides, and hydroxides.
(160) In at least one embodiment, the analyte:metal molar ratio is about 1:1, about 2:1, about 3:1, about 4:1, about 5:1, or about 6:1.
(161) The term enantiomeric composition refers to the enantiomeric ratio and/or enantiomeric excess of an analyte. The enantiomeric ratio (er) is the ratio of the percentage of one analyte enantiomer in a mixture to that of the other enantiomer. The enantiomeric excess (ee) is the difference between the percentage of one analyte enantiomer and the percentage of the other analyte enantiomer. For example, a sample which contains 75% L-analyte and 25% D-analyte will have an enantiomeric excess of 50% of L-analyte and an enantiomeric ratio (D:L) of 25:75.
(162) In the analytical methods described herein, the enantiomeric composition of the analyte can be determined by correlating the chiroptical signal of the probe-analyte complexes that form to that of standard samples. The chiroptical signal of the complexes can be measured using standard techniques, which will be apparent to the skilled artisan. Such techniques include circular dichroism spectroscopy (e.g., S
(163) In the analytical methods described herein, the concentration of the analyte can be determined by correlating an optical spectroscopic signal of the probe-analyte complexes that form to that of standard samples. The optical spectroscopic signal can be measured using standard techniques, which will be apparent to the skilled artisan. Such techniques include, but are not limited to, UV spectroscopy (P
(164) In the analytical methods described herein, the absolute configuration of the analyte can be assigned from the chiroptical signal of the probe-analyte complexes that form. This assignment can be based on the sense of chirality induction with a reference or by analogy. The chiroptical signal of the complexes can be measured using standard techniques, which will be apparent to the skilled artisan. Such techniques include circular dichroism spectroscopy (e.g., S
(165) The analytical methods provide, among other things, rapid and convenient tools for determining the enantiomeric composition, concentration, and absolute configuration of chiral analytes. These analytical methods may be particularly useful, for example, for evaluating reactions whose desired product is chiral. For example, the present methods can be used to determine the enantiomeric composition of the desired product, thus indicating the stereoselectivity of the reaction. Similarly, the present methods can be used to determine the concentration of the total product, the desired isomer, or both, thus indicating the overall or individual yield of the reaction. In certain embodiments, the analyte is a reaction product and the stereoselectivity and yield of the reaction are determined by determining the enantiomeric composition and concentration of the analyte.
(166) Previous methods using metal-based probes to analyze chiral analytes by detecting changes in their absorption and/or transmission spectra have relied on probes that include an auxiliary ligand or group, as it was thought that the ligand or group was needed in order for the analyte to cause detectable and/or quantifiable changes in the spectra at high wavelength, e.g., above 300 nm. As demonstrated herein, however, absorption and transmission techniques can be used to detect the coordination of a chiral analyte with a metal salt without the need for an auxiliary ligand or group. Thus, in certain embodiments, the analytical methods are carried out using absorption spectroscopy, transmission spectroscopy, or both. As will be apparent to the skilled artisan, these techniques could further be combined with emission spectroscopy to determine the analyte concentration. For example, absorption spectroscopy and/or transmission spectroscopy could be used to determine the enantiomeric composition and/or absolute configuration of the analyte and emission spectroscopy could be used to determine the analyte concentration.
(167) In certain embodiments, the analytical methods are carried out under aerobic conditions (e.g., under air or in an aqueous environment). Most metals that can have more than one oxidation state oxidize slowly enough in aerobic conditions that they are unlikely to oxidize to any statistically significant degree in the time it would take for any analyte in the sample to coordinate with the metal. However, cobalt (II) salts quickly oxidize in aerobic conditions. Thus, the use of another oxidizing agent (e.g., H.sub.2O.sub.2, O.sub.2) may be helpful when using cobalt (II) salts in an aerobic environment to insure that all of the metal ions are in a single oxidation state (Co.sup.3+) when any spectra are taken following sample addition. Alternatively, more rigorous conditions, such as the use of an anaerobic environment, could be used to avoid having spectra taken after only partial oxidation of cobalt (II) to cobalt (III).
(168) In certain embodiments, the analytical methods are carried out under oxidizing conditions (e.g., in H.sub.2O.sub.2, O.sub.2, air).
(169) The analytical methods could also optionally be carried out in the presence of a base. The use of a base may be helpful when the analyte is an acid (e.g., a carboxylic acid) or when an acid may be generated in situ. Adding an equivalent of base could also be helpful to avoid side reactions. In certain embodiments of the analytical method disclosed herein, a stoichiometric amount in regard to the analyte of base is added to the reaction (e.g., when the analyte is a carboxylic acid). Suitable bases include both organic and inorganic bases (or mixtures thereof). Exemplary bases include, but are not limited to: alkoxides such as sodium tert-butoxide; alkali metal amides such as sodium amide, lithium diisopropylamide, and alkali metal bis(trialkylsilyl)amide, e.g., such as lithium bis(trimethylsilyl)amide (LiHMDS) or sodium bis(trimethylsilyl)amide (NaHMDS); tertiary amines (e.g., triethylamine, trimethylamine, 4-(dimethylamino)pyridine (DMAP), 1,5-diazabicycl[4.3.0]non-5-ene (DBN), 1,5-diazabicyclo[5.4.0]undec-5-ene (DBU); alkali or alkaline earth carbonate, bicarbonate or hydroxide (e.g., sodium, magnesium, calcium, barium, potassium carbonate, phosphate, hydroxide and bicarbonate); and ammonium hydroxides (e.g., tetrabutylammonium hydroxide (TBAOH)).
(170) In certain embodiments, the contacting step is carried out in a solvent selected from aqueous solvents, protic solvents, aprotic solvents, and any combination thereof. Exemplary solvents include, but are not limited to, chloroform, dichloromethane, acetonitrile, toluene, tetrahydrofuran, methanol, ethanol, isopropanol, water, dimethyl sulfoxide (DMSO), dimethylformamide (DMF), hexane, hexane isomers, pentane, pentane isomers, toluene, aromatic solvents, ether, dichloroethane, acetone, ethyl acetate, butanone, diethyl ether, dioxane, tert-butyl methyl ether, tetrachloroethane, and mixtures of any combination thereof. Additionally, the contacting can be carried out in air, and/or in an aqueous environment.
(171) In at least one embodiment, contacting is carried out for about 1 to about 300 minutes (e.g., carried out for a duration range having an upper limit of about 5, about 10, about 20, about 30, about 40, about 50, about 60, about 70, about 80, about 90, about 100, about 110, about 120, about 130, about 140, about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, about 250, about 260, about 270, about 280, about 290, or about 300 minutes, and a lower limit of about 1, about 5, about 10, about 20, about 30, about 40, about 50, about 60, about 70, about 80, about 90, about 100, about 110, about 120, about 130, about 140, about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, about 250, about 260, about 270, about 280, or about 290 minutes, or any combination thereof). In all embodiments, contacting is carried out for a time that is sufficient for any analyte present in the sample to coordinate with the metal. As will be apparent to the skilled artisan, the speed at which coordination takes place will depend on various factors, including the particular probe selected and the analyte, whether a catalyst is present, and the temperature.
(172) As will be apparent to the skilled chemist, the analytical methods may be carried out at room or moderate temperatures (e.g., about 25 C. to about 50 C.), at high temperatures (e.g., about 50 C. to about 100 C.), or at low temperatures (e.g., below about 25 C., e.g., below about 25 C., below about 20 C., below about 15 C., below about 10 C., below about 5 C., below about 0 C., below about 5 C., below about 10 C., below about 15 C., below about 20 C., below about 25 C., below about 30 C., below about 35 C., below about 40 C., below about 45 C., below about 50 C., below about 55 C., below about 60 C., below about 65 C., below about 70 C., or below about 75 C., preferably no lower than about 78 C.). For example, the methods may be carried out in a temperature range with an upper limit of about 100 C., about 95 C., about 90 C., about 85 C., about 80 C., about 75 C., about 70 C., about 65 C., about 60 C., about 55 C., about 50 C., about 45 C., about 40 C., about 35 C., about 30 C., about 25 C., about 20 C., about 15 C., about 10 C., about 5 C., about 0 C., about 5 C., about 10 C., about 15 C., about 20 C., about 25 C., about 30 C., about 35 C., about 40 C., about 45 C., about 50 C., about 55 C., about 60 C., about 65 C., about 70 C., or about 75 C., and a lower limit of about 90 C., about 85 C., about 80 C., about 75 C., about 70 C., about 65 C., about 60 C., about 55 C., about 50 C., about 45 C., about 40 C., about 35 C., about 30 C., about 25 C. about 20 C., about 15 C., about 10 C., about 5 C., about 0 C., about 5 C., about 10 C., about 15 C., about 20 C., about 25 C., about 30 C., about 35 C., about 40 C., about 45 C., about 50 C., about 55 C., about 60 C., about 65 C., about 70 C., about 75 C., or about 78 C., or any combination thereof. By way of example, the temperature could be increased to speed up the coordination reaction or decreased to prevent side reactions that may occur at certain temperatures.
(173) Preferences and options for a given aspect, feature, embodiment, or parameter of the technology described herein should, unless the context indicates otherwise, be regarded as having been disclosed in combination with any and all preferences and options for all other aspects, features, embodiments, and parameters of the technology.
(174) The present technology may be further illustrated by reference to the following examples.
EXAMPLES
(175) The examples below are intended to exemplify the practice of embodiments of the disclosure but are by no means intended to limit the scope thereof.
Example 1CD Analysis
(176) The scope of enantioselective chemosensing with ligand-free metal was tested with amino acids 1-18, -hydroxy acid 19-24, amino alcohols 25-33, and amines 34-37 (only one enantiomer shown).
(177) ##STR00001## ##STR00002## ##STR00003## ##STR00004## ##STR00005##
(178) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and portions of 0.5 mL were transferred to 4 mL vials. Solutions of the substrates were prepared in MeOH (0.50 M). For substrates 1 to 24, an equimolar amount of TBAOH (1.0 M in MeOH) was added. To each vial containing 0.5 mL of the Co(II) stock solution were added three equivalents of the substrate followed by one equivalent (1.14 L) of H.sub.2O.sub.2 (30% w/w aqueous solution). In all cases, a distinct color change was observed upon addition of the chiral substrates and upon addition of the oxidant. Control NMR experiments showed that the substrates do not react with H.sub.2O.sub.2 under these conditions. The mixture was stirred for 1 hour at 25 C. and CD analysis was conducted either at 1.8 mM (amino acids, -hydroxy acids and amino alcohols) or 0.5 mM (diamines) in MeOH. CD spectra were collected with a standard sensitivity of 100 mdeg, a data pitch of 2.0 nm, a band width of 1 nm, a scanning speed of 500 nm min-1, and a response of 0.5 s using a quartz cuvette (1 cm path length) (
Example 2Mechanistic Analysis
(179) UV Analysis of the Complex Formation
(180) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and 0.5 mL portions were transferred into 4 mL vials. A solution of (R)-1 was prepared in MeOH (0.50 M) and was treated with an equimolar amount of TBAOH (1.0 M in MeOH). To each vial containing 0.5 mL of the Co(II) stock solution were added increasing amounts of the substrate (0.0, 0.2, 0.4, 0.6, 0.8, 1.0, 2.0, 3.0, 4.0, 5.0 equivalents relative to Co(II)) followed by one equivalent (1.14 L) of H.sub.2O.sub.2 (30% w/w aqueous solution). UV analysis was performed at 1.8 mM in MeOH with an average scanning time of 0.1 s, a data interval of 1 nm, and a scan rate of 600 nm/min (
(181) Completion of the Complex Formation by CD Spectroscopy
(182) The CD spectra of a mixture of Co(NO.sub.3).sub.2.Math.6H.sub.2O, (R)-32, and H.sub.2O.sub.2 prepared as described herein were collected after 1, 3, 5, 10, 15, 30, 45, 60, and 90 minutes using sample concentrations of 1.8 mM in MeOH (
(183) Correlation Between Concentration and CD Signal of (R,S)-25
(184) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and 0.5 mL portions were transferred into 4 mL vials. To the solutions of Co(NO.sub.3).sub.2.Math.6H.sub.2O were added varying amounts of (R,S)-25 (0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 260, 280, and 300 mol %), and one equivalent (1.14 L) of H.sub.2O.sub.2. The mixture was stirred for 1 hour at 25 C. prior to CD analysis. CD analysis was performed as described herein at 1.8 mM in MeOH (
(185) Complex Stoichiometry by MS Analysis
(186) Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.01 mmol in 0.5 mL MeOH), (S)-1 (0.06 mL, 0.5 M MeOH/KOH 1:1) and H.sub.2O.sub.2 (1.14 L, 30% w/w in H.sub.2O) were combined and the mixture was stirred for 1 hour prior to electrospray mass spectrometry (positive ion mode) analysis (metal complex [CoC.sub.15H.sub.30N.sub.3O.sub.6]=407 m/z) (
(187) Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.01 mmol in 0.5 mL MeOH), (S)-5 (0.06 mL, 0.5 M MeOH/KOH 1:1) and H.sub.2O.sub.2 (1.14 L, 30% w/w in H.sub.2O) were combined and the mixture was stirred for 1 hour prior to electrospray mass spectrometry (positive ion mode) analysis (metal complex [CoC.sub.27H.sub.30N.sub.3O.sub.6]=551 m/z) (
(188) Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.01 mmol in 0.5 mL MeOH), (S)-10 (0.06 mL, 0.5 M MeOH/KOH 1:1) and H.sub.2O.sub.2 (1.14 L, 30% w/w in H.sub.2O) were combined and the mixture was stirred for 1 hour prior to electrospray mass spectrometry (positive ion mode) analysis (metal complex [CoC.sub.27H.sub.30N.sub.3O.sub.9]=599 m/z) (
(189) Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.01 mmol in 0.5 mL MeOH), (S)-16 (0.06 mL, 0.5 M MeOH/KOH 1:1) and H.sub.2O.sub.2 (1.14 L, 30% w/w in H.sub.2O) were combined and the mixture was stirred for 1 hour prior to electrospray mass spectrometry (positive ion mode) analysis (metal complex [CoC.sub.33H.sub.33N.sub.6O.sub.6]=668 m/z) (
(190) Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.01 mmol in 0.5 mL MeOH), (S)-17 (0.06 mL, 0.5 M MeOH/KOH 1:1) and H.sub.2O.sub.2 (1.14 L, 30% w/w in H.sub.2O) were combined and the mixture was stirred for 1 hour prior to electrospray mass spectrometry (positive ion mode) analysis (metal complex [Co.sub.3C.sub.36H.sub.48N.sub.18O.sub.12].sup.3+=367 m/z) (
(191) Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.01 mmol in 0.5 mL MeOH), (R,S)-25 (0.06 mL, 0.5 M MeOH) and H.sub.2O.sub.2 (1.14 L, 30% w/w in H.sub.2O) were combined and the mixture was stirred for 1 hour prior to electrospray mass spectrometry (positive ion mode) analysis (metal complex [CoC.sub.27H.sub.30N.sub.3O.sub.3]=503 m/z) (
(192) Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.01 mmol in 0.5 mL MeOH), (S)-29 (0.06 mL, 0.5 M MeOH) and H.sub.2O.sub.2 (1.14 L, 30% w/w in H.sub.2O) were combined and the mixture was stirred for 1 hour prior to electrospray mass spectrometry (positive ion mode) analysis (metal complex [Co.sub.3C.sub.48H.sub.60N.sub.6O.sub.6].sup.3+=331 m/z) (
(193) Significance of Oxidation of Co(II) to Co(III)
(194) The complexes formed from Co(II) and four different analytes were treated with varying amounts of H.sub.2O.sub.2. A solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and 0.5 mL portions were transferred into 4 mL vials. Solutions of 1, 24, 25, or 34 (0.50 M in MeOH) were prepared. For substrates 1 and 24, an equimolar amount of TBAOH (1.0 M in MeOH) was also added. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents (0.06 mL) of the substrate and varying amounts of H.sub.2O.sub.2 (0 mol % (inert atmosphere), 50 mol %, and 100 mol % relative to Co(II)). CD analysis was performed as described herein (
(195) Solvent Effects
(196) A solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and 0.5 mL portions were transferred into 4 mL vials. Solutions of 1, 24, 25, or 34 (0.50 M in MeOH) were prepared. For substrates 1 and 24, an equimolar amount of TBAOH (1.0 M in MeOH) was also added. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents (0.06 mL) of the substrate and one equivalent (1.14 L) of H.sub.2O.sub.2 (30% w/w aqueous solution). CD analysis was performed by taking an aliquot (0.2 mL of 1, 24, and 25, or 0.05 mL of 34) of the reaction mixture and diluting it further with 2.0 mL of either MeOH, deionized H.sub.2O, acetonitrile, or DMSO (
(197) Anion Effects
(198) Stock solutions of Co(ClO.sub.4).sub.2.Math.6H.sub.2O, Co(NO.sub.3).sub.2.Math.6H.sub.2O and CoCl.sub.2.Math.6H.sub.2O (0.02 M) in MeOH were prepared and 0.5 mL portions were transferred into 4 mL vials. Solutions of 1, 23, 25, or 34 (0.50 M in MeOH) were prepared. For substrates 1 and 23, an equimolar amount of TBAOH (1.0 M in MeOH) was also added. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents (0.06 mL) of the substrate and one equivalent (1.14 L) of H.sub.2O.sub.2 (30% w/w aqueous solution). CD analysis was performed by taking an aliquot (0.2 mL of 1, 24, and 25, or 0.05 mL of 34) of the reaction mixture and diluting it further with 2.0 mL of MeOH (
Example 3Quantitative EE Analysis of Various Chiral Analytes
(199) ee Determination of Valine
(200) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of 1 (0.50 M in MeOH) at varying ee compositions (+100.0, +80.0, +60.0, +40.0, +20.0, 0.0, 20.0, 40.0, 60.0, 80.0, 100.0) and an equimolar amount of TBAOH were prepared. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents of 1 (0.06 mL) and one equivalent (1.14 L) of H.sub.2O.sub.2. The CD analysis was carried out as described herein (
(201) Five scalemic samples of 1 were prepared and then treated with the Co(II) salt as described herein. Using the linear regression equations obtained from the calibration curves and the measured CD amplitudes at 504 and 624 nm, the enantiomeric excess and the absolute configuration of the major enantiomer were determined, as shown in Table 1.
(202) TABLE-US-00001 TABLE 1 Enantiomeric excess and absolute configuration of scalemic samples of 1 measured using Co(NO.sub.3).sub.26H.sub.2O Sample Chiroptical Sensing Chiroptical Sensing Composition (504 nm) (624 nm) Abs. Actual Abs. Calculated Abs. Calculated Average Config. % ee Config..sup.a % ee.sup.b Config..sup.a % ee.sup.b % ee S 88.0 S 83.4 S 88.1 85.8 S 62.0 S 59.2 S 66.1 62.7 S 22.0 S 23.3 S 28.3 25.8 R 16.0 R 13.7 R 14.3 14.0 R 94.0 R 95.7 R 92.1 93.9 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
ee Determination of 1-Aminoethylphosphonic Acid
(203) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of 18 (0.50 M in MeOH) at varying ee compositions (+100.0, +80.0, +60.0, +40.0, +20.0, 0.0, 20.0, 40.0, 60.0, 80.0, 100.0) and an equimolar amount of TBAOH were prepared. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents of 18 (0.06 mL) and one equivalent (1.14 L) of H.sub.2O.sub.2. The CD analysis was carried out as described herein (
(204) Five scalemic samples of 18 were prepared and then treated with the Co(II) salt as described herein. Using the linear regression equations obtained from the calibration curves and the measured CD amplitudes at 410 and 550 nm, the enantiomeric excess and the absolute configuration of the major enantiomer were determined, as shown in Table 2.
(205) TABLE-US-00002 TABLE 2 Enantiomeric excess and absolute configuration of scalemic samples of 18 measured using Co(NO.sub.3).sub.26H.sub.2O Sample Chiroptical Sensing Chiroptical Sensing Composition (410 nm) (550 nm) Abs. Actual Abs. Calculated Abs. Calculated Average Config. % ee Config..sup.a % ee.sup.b Config..sup.a % ee.sup.b % ee R 88.0 R 90.1 R 86.9 88.5 R 62.0 R 58.1 R 58.7 58.4 R 22.0 R 17.8 R 22.1 20.0 S 16.0 S 21.5 S 16.0 18.8 S 94.0 S 88.6 S 88.3 88.5 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
ee Determination of 2-Chloromandelic Acid
(206) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of 24 (0.50 M in MeOH) at varying ee compositions (+100.0, +80.0, +60.0, +40.0, +20.0, 0.0, 20.0, 40.0, 60.0, 80.0, 100.0) and an equimolar amount of TBAOH were prepared. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents of 24 (0.06 mL) and one equivalent (1.14 L) of H.sub.2O.sub.2. The CD analysis was carried out as described herein (
(207) Five scalemic samples of 24 were prepared and then treated with the Co(II) salt as described herein. Using the linear regression equations obtained from the calibration curves and the measured CD amplitudes at 450 and 600 nm, the enantiomeric excess and the absolute configuration of the major enantiomer were determined, as shown in Table 3.
(208) TABLE-US-00003 TABLE 3 Enantiomeric excess and absolute configuration of scalemic samples of 24 measured using Co(NO.sub.3).sub.26H.sub.2O Sample Chiroptical Sensing Chiroptical Sensing Composition (450 nm) (600 nm) Abs. Actual Abs. Calculated Abs. Calculated Average Config. % ee Config..sup.a % ee.sup.b Config..sup.a % ee.sup.b % ee R 88.0 R 91.1 R 84.1 87.6 R 62.0 R 54.7 R 59.9 57.3 R 22.0 R 27.0 R 20.3 23.7 S 16.0 S 19.5 S 17.8 18.7 S 94.0 S 92.1 S 92.6 92.4 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
ee Determination of cis-1-Amino-2-indanol
(209) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of 25 (0.50 M in MeOH) at varying ee compositions (+100.0, +80.0, +60.0, +40.0, +20.0, 0.0, 20.0, 40.0, 60.0, 80.0, 100.0) were prepared. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents of 25 (0.06 mL) and one equivalent (1.14 L) of H.sub.2O.sub.2. The CD analysis was carried out as described herein (
(210) Five scalemic samples of 25 were prepared and then treated with the Co(II) salt as described herein. Using the equations obtained from the calibration curves and the measured CD amplitudes at 400 and 560 nm, the enantiomeric excess and the absolute configuration of the major enantiomer were determined, as shown in Table 4.
(211) TABLE-US-00004 TABLE 4 Enantiomeric excess and absolute configuration of scalemic samples of 25 measured using Co(NO.sub.3).sub.26H.sub.2O Sample Chiroptical Sensing Chiroptical Sensing Composition (400 nm) (560 nm) Abs. Actual Abs. Calculated Abs. Calculated Average Config. % ee Config..sup.a % ee.sup.b Config..sup.a % ee.sup.b % ee R, S 88.0 R, S 85.1 R, S 82.3 83.7 R, S 62.0 R, S 64.0 R, S 61.0 62.5 R, S 22.0 R, S 25.6 R, S 27.2 26.4 S, R 16.0 S, R 20.1 S, R 14.5 17.3 S, R 94.0 S, R 90.0 S, R 97.6 93.8 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
ee Determination of 1,2-diphenylethylenediamine
(212) A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of 34 (0.50 M in MeOH) at varying ee compositions (+100.0, +80.0, +60.0, +40.0, +20.0, 0.0, 20.0, 40.0, 60.0, 80.0, 100.0) were prepared. To each vial containing 0.5 mL of the Co(II) solution were added three equivalents of 34 (0.06 mL) and one equivalent (1.14 L) of H.sub.2O.sub.2. The CD analysis was carried out as described herein (
(213) Five scalemic samples of 34 were prepared and then treated with the Co(II) salt as described herein. Using the equations obtained from the calibration curves and the measured CD amplitudes at 390 and 520 nm, the enantiomeric excess and the absolute configuration of the major enantiomer were determined, as shown in Table 5.
(214) TABLE-US-00005 TABLE 5 Enantiomeric excess and absolute configuration of scalemic samples of 34 measured using Co(NO.sub.3).sub.26H.sub.2O Sample Chiroptical Sensing Chiroptical Sensing Composition (390 nm) (520 nm) Abs. Actual Abs. Calculated Abs. Calculated Average Config. % ee Config..sup.a % ee.sup.b Config..sup.a % ee.sup.b % ee R, R 88.0 R, R 89.9 R, R 90.0 90.0 R, R 62.0 R, R 62.6 R, R 60.3 61.5 R, R 22.0 R, R 24.2 R, R 17.7 21.0 S, S 16.0 S, S 16.9 S, S 18.3 17.6 S, S 94.0 S, S 92.3 S, S 91.7 92.0 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
Example 4Simultaneous Determination of the Concentration and % EE of Cis-1-Amino-2-Indanol
(215) The change in the UV spectra upon addition of various amounts of 25 were analyzed. A stock solution of Co(NO.sub.3).sub.2.Math.6H.sub.2O (0.02 M) in MeOH was prepared and 0.5 mL portions were transferred into 4 mL vials. To the solutions of Co(NO.sub.3).sub.2.Math.6H.sub.2O were added varying amounts of 25 (0, 20, 40, 60, 80, 100, 120, 140, 160, 180, 200, 220, 240, 260, 280, and 300 mol %), and one equivalent (1.14 L) of H.sub.2O.sub.2. UV spectra were collected at 1.8 mM in MeOH with an average scanning time of 0.1 s, a data interval of 1 nm, and a scan rate of 600 nm/min (
(216) Nine solutions of 25 at varying concentrations and % ee were prepared and analyzed as described herein. Using the linear regression equation obtained from the calibration curve and the UV absorbance at 535 nm, the concentrations of these samples were determined, as shown in Table 6 below.
(217) The samples were subjected to CD analysis. The amplitude obtained at 560 nm was used with the following formulae to calculate the corresponding % ee (equation 1 was obtained from the plot of the CD amplitudes measured at 560 nm plotted against % ee, see
(218)
(219) TABLE-US-00006 TABLE 6 Summary of the results obtained by using the regression equations to determine the absolute configuration, concentration and % ee of 9 scalemic samples of 25. Actual Composition CD Sensing Results Concen- Concen- Abs. tration Abs. tration Config. (mM) % ee Config..sup.a (mM) % ee.sup.b % error (S, R) 16.6 81.0 (S, R) 17.1 74.9 6.1 (R, S) 24.2 74.0 (R, S) 23.8 65.4 8.6 (S, R) 31.2 65.0 (S, R) 31.8 63.7 1.3 (R, S) 34.6 43.0 (R, S) 36.0 37.6 5.4 (S, R) 42.2 35.0 (S, R) 42.0 37.1 2.1 (R, S) 47.4 64.0 (R, S) 48.3 62.4 1.6 (S, R) 51.6 55.0 (S, R) 53.5 56.1 1.1 (R, S) 56.6 25.0 (R, S) 56.7 21.0 4.0 (S, R) 58.8 16.0 (S, R) 59.3 18.3 2.3 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
Discussion of Examples 1-4
(220) In the search for a chiroptical sensing method that has the desirable features listed herein, cobalt coordination chemistry was used, partly because of the long history of optically active [Co(en).sub.3].sup.3+ and other Werner complexes (Werner, A., Chem. Ber. 44:2445-2455 (1911); Werner, A., Chem. Ber. 44:3279-3284 (1911); Werner, A., Chem. Ber. 44:3272-3278 (1911); Werner, A., Chem. Ber. 45:121-130 (1912), which are hereby incorporated by reference in their entirety), the wealth of spectroscopic, crystallographic and molecular recognition studies available in the literature (Fenton et al., Inorg. Chim. Acta 236:109-115 (1995); Mizuno et al., Tetrahedron 55:9455-9468 (1999); Fujii et al., Bull. Chem. Soc. Jpn. 54:2029-2038 (1981); Fujii et al., J. Chem. Soc. Chem. Commun. 415-417 (1985); Dzygiel et al., Eur. J. Org. Chem. 1253-1264 (2008); Jorge et al., J. Am. Chem. Soc. 127:975-985 (2005); Kim et al., J. Am. Chem. Soc. 127:16776-16777 (2005); Tashiro et al., Inorg. Chem. 50:4-6 (2011); Ghosh et al., Coord. Chem. Rev. 350:30-48 (2017); Gregolinski et al., Inorg. Chem. 55:633-643 (2016); Arrico et al., Org. Biomol. Chem. 15:9800-9803 (2017), which are hereby incorporated by reference in their entirety), and the general utility, for example in asymmetric catalysis (Pelissier, H. & Clavier, H. Chem. Rev. 114:2775-2823 (2014); Ehnbom et al., ACS Cent. Sci. 1:50-56 (2015); Ehnbom et al., Chem. Soc. Rev. 45:6799-6811 (2016), which are hereby incorporated by reference in their entirety). Cobalt is a physiologically important, earth-abundant transition metal and several inexpensive cobalt salts including Co(NO.sub.3).sub.2, Co(ClO.sub.4).sub.2 and CoCl.sub.2 are commercially available. Because ligand exchange at a cobalt(II) center is generally fast compared to Co(III) complexes it was decided to investigate the possibility of auxiliary-free chirality sensing by mixing Co(NO.sub.3).sub.2 with a chiral substrate in the presence of stoichiometric amounts of hydrogen peroxide to accelerate the assembly of stable, easy to handle adducts for rapid chiroptical analysis. In the hope to demonstrate a wide application scope this simple mix-and-measure protocol was applied to the enantiomers of amino acids 1-17, amino phosphonic acid 18, hydroxy acids 19-24, amino alcohols 25-33 and diamines 34 and 35 using methanol as solvent (
(221) Strong induced CD (ICD) signals were observed at high wavelengths, typically between 400 and 700 nm, with all 35 chirality sensing targets. The generation of ICD effects above 300 nm is preferable because it is likely to eliminate interference from chiral impurities when quantitative ee analysis is attempted. Representative examples of the Cotton effects obtained with aliphatic and aromatic substrates representing a broad range of important classes of chiral compounds are shown in
(222) With a practical and widely useful chirality sensing protocol in hand, the feasibility of quantitative ee determination was explored. To equally represent amino acids, amino phosphonic acids, hydroxy acids, amino alcohols and diamines 1, 18, 24, 25 and 34 were chosen as test compounds. Perfectly linear correlations between the amplitudes of the ICD signals and the analyte % ee were obtained for 1, 18 (
(223) 25 nonracemic mixtures were prepared of 1, 18, 24, 25 and 34, respectively, covering a wide range of enantiomeric excess to demonstrate the usefulness of the chirality sensing assay described herein for quantitative stereochemical analysis (Table 7). Using the simple mix-and-measure protocol and the average of two ICD signals, the absolute configuration of the major enantiomer and the ee values were able to be correctly determined with a maximum error margin of 5.5% which is generally considered acceptable for high-throughput screening applications (Table 7, entry 10). For example, sensing of samples containing the R-enantiomer of valine in 16.0 and 94.0% ee, respectively, gave 14.0 and 93.9% ee (entries 4 and 5). The averaged error of the % ee analysis of the five valine samples is 1.7% ee (entries 1-5). The averaged error of the % ee determination of 18, 24, 25 and 34 were calculated as 2.9, 2.1, 2.1, and 1.4, respectively (entries 6-25).
(224) TABLE-US-00007 TABLE 7 Chirality sensing of nonracemic mixtures of 1, 18, 24, 25 and 34. Sample Composition Chiroptical Sensing Entry AC % ee AC.sup.a % ee (nm).sup.b Average % ee 1 (S)-1 88.0 S 83.4 (505) 88.1 (625) 85.8 2 (S)-1 62.0 S 59.2 (505) 66.1 (625) 62.7 3 (S)-1 22.0 S 23.3 (505) 28.3 (625) 25.8 4 (R)-1 16.0 R 13.7 (505) 14.3 (625) 14.0 5 (R)-1 94.0 R 95.7 (505) 92.1 (625) 93.9 6 (R)-18 88.0 R 90.1 (410) 86.9 (550) 88.5 7 (R)-18 62.0 R 58.1 (410) 58.7 (550) 58.4 8 (R)-18 22.0 R 17.8 (410) 22.1 (550) 20.0 9 (S)-18 16.0 S 21.5 (410) 16.0 (550) 18.8 10 (S)-18 94.0 S 88.6 (410) 88.3 (550) 88.5 11 (R)-24 88.0 R 91.1 (450) 84.1 (600) 87.6 12 (R)-24 62.0 R 54.7 (450) 59.9 (600) 57.3 13 (R)-24 22.0 R 27.0 (450) 20.3 (600) 23.7 14 (S)-24 16.0 S 19.5 (450) 17.8 (600) 18.7 15 (S)-24 94.0 S 92.1 (450) 92.6 (600) 92.4 16 (R, S)-25 88.0 R, S 85.1 (400) 82.3 (560) 83.7 17 (R, S)-25 62.0 R, S 64.0 (400) 61.0 (560) 62.5 18 (R, S)-25 22.0 R, S 25.6 (400) 27.2 (560) 26.4 19 (S, R)-25 16.0 S, R 20.1 (400) 14.5 (560) 17.3 20 (S, R)-25 94.0 S, R 90.0 (400) 97.6 (560) 93.8 21 (R, R)-34 88.0 R, R 89.9 (390) 90.0 (520) 90.0 22 (R, R)-34 62.0 R, R 62.6 (390) 60.3 (520) 61.5 23 (R, R)-34 22.0 R, R 24.2 (390) 17.7 (520) 21.0 24 (S, S)-34 16.0 S, S 16.9 (390) 18.3 (520) 17.6 25 (S, S)-34 94.0 S, S 92.3 (390) 91.7 (520) 92.0 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
(225) The chiroptical sensing also coincides with a visible color change that can be quantified by UV spectroscopy. For example, addition of increasing amounts of 25 to the cobalt sensor yields a new absorption band at approximately 550 nm (
(226) TABLE-US-00008 TABLE 8 Combined sensing of the absolute configuration, ee and concentration of samples of cis-1-amino-2-indanol, 25. Sample Composition CD Sensing Results Entry AC Conc. (mM) % ee AC.sup.a Conc. (mM) % ee.sup.b 1 (S, R) 16.6 81.0 (S, R) 17.1 74.9 2 (R, S) 24.2 74.0 (R, S) 23.8 65.4 3 (S, R) 31.2 65.0 (S, R) 31.8 63.7 4 (R, S) 34.6 43.0 (R, S) 36.0 37.6 5 (S, R) 42.2 35.0 (S, R) 42.0 37.1 6 (R, S) 47.4 64.0 (R, S) 48.3 62.4 7 (S, R) 51.6 55.0 (S, R) 53.5 56.1 8 (R, S) 56.6 25.0 (R, S) 56.7 21.0 9 (S, R) 58.8 16.0 (S, R) 59.3 18.3 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
(227) Auxiliary-free chirality sensing of the chiral analytes depicted above or others including monoamines and carboxylic acids is also possible, and one can use other metals, for example Fe(II), Fe (III), Cu(I), Cu(II), Ce(III), Pd(II), Mn(II), Rh(III) as shown herein.
Example 5General Sensing Procedure
(228) A stock solution of the metal salt (0.02 M) in either MeOH [Pd(NO.sub.3).sub.2], ACN [Cu(ACN).sub.4PF.sub.6], DMSO [FeCl.sub.2.Math.4H.sub.2O, FeCl.sub.3.Math.6H.sub.2O, MnCl.sub.2.Math.4H.sub.2O, CuCl.sub.2.Math.2H.sub.2O, Ce(NO.sub.3).sub.3.Math.6H.sub.2O] or H.sub.2O [RhCl.sub.3.Math.3H.sub.2O] was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of the analytes were prepared in either MeOH or DMSO (0.50 M). For substrates carrying an acidic functional group, an equimolar amount of TBAOH (1.0 M in MeOH) was added. The mixtures were stirred for 1 hour at 25 C. and CD analysis was conducted after diluting the mixture with either MeOH, ACN, or DMSO to the final concentration given in the figure descriptions. CD spectra were collected with a standard sensitivity of 100 mdeg, a data pitch of 2.0 nm, a band width of 2 nm, a scanning speed of 500 nm min.sup.1, and a response of 0.5 s using a quartz cuvette (1 cm path length). The data were baseline corrected and smoothed using a binomial equation. Control experiments with the chiral analytes showed that the free substrates are CD silent in the region of interest.
Example 6Substrate Scope
(229) The scope of enantioselective chemosensing was tested with amino acids 1, 2, 4, 5, 6, 8, 9, 10, 15, 17, -hydroxy acids 19-24, amino alcohols 25-28, 31, amines 34-37 and carboxylic acid 38 (only one enantiomer shown).
(230) ##STR00006## ##STR00007## ##STR00008##
(231)
(232) TABLE-US-00009 TABLE 9 Comparison of the chirality sensing with FeCl.sub.36H.sub.2O and CuCl.sub.22H.sub.2O Substrate FeCl.sub.3 CuCl.sub.2 1 + + 2 + + 4 + x 5 + x 6 + x 8 + x 9 + + 10 + x 15 + x 17 + + 19 + + 20 + + 21 + 22 + 23 + + 24 + + 25 + + 26 + + 27 + 28 + + 31 + + 34 + 35 + 36 + 37 + 38 + +: Suitable for ee determination; x: insufficient ICD intensities; : not suitable for ee quantification.
Example 7Mechanistic Studies
(233) UV Titration Analysis
(234) A stock solution of Cu(Cl).sub.2.Math.2H.sub.2O or Fe(Cl).sub.3.Math.6H.sub.2O (1 M) in DMSO was prepared and 0.1 mL portions were transferred into 4 mL vials. The portions were then diluted with 0.4 mL DMSO. A solution of (S,R)-25 was prepared in DMSO (0.50 M). To each vial containing 0.5 mL of the Cu(II) or Fe(III) stock solutions were added increasing amounts of the substrate (0.0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0 equivalents relative to Cu(II) or Fe(III)). UV analysis was performed at 0.5 or 0.25 mM in DMSO with an average scanning time of 0.1 s, a data interval of 1 nm, and a scan rate of 600 nm/min.
(235)
(236)
(237) CD Titration Analysis
(238) The CD of the reaction of probe CuCl.sub.2.Math.2H.sub.2O, and analyte (S,R)-25 (0-5 equivalents), as well as probe FeCl.sub.3.Math.6H.sub.2O, and analyte (R,R)-19 (0-5 equivalents) were obtained using the analytical method described herein. The concentrations for each reaction are disclosed in the brief description of the figures.
(239)
(240) As shown in
(241)
(242) Anion Effects
(243) Stock solutions of CuCl.sub.2.Math.2H.sub.2O, Cu(OAc).sub.2, Cu(CF.sub.3CO.sub.2).sub.2, Cu(NO.sub.3).sub.2.Math.2.5H.sub.2O, CuSO.sub.4.Math.5H.sub.2O and CuClO.sub.4.Math.6H.sub.2O (0.02 M) in DMSO were prepared and 0.5 mL portions were transferred into 4 mL vials. A solution of 25 (0.50 M in DMSO) was prepared. To each vial containing 0.5 mL of the Cu(II) solution were added two equivalents (0.04 mL) of the substrate. CD analysis was performed by taking an aliquot (0.1 mL) of the reaction mixture and diluting it further with 2.0 mL of DMSO.
(244) Stock solutions of FeCl.sub.3.Math.6H.sub.2O, Fe(ClO.sub.4).sub.3 and Fe(NO.sub.3).sub.3.Math.9H.sub.2O (0.0011 M) in DMSO were prepared and 0.5 mL portions were transferred into 4 mL vials. A solution of (R,R)-19 (0.17 M in water) was prepared. An equimolar amount of TBAOH (1.0 M in MeOH) was also added. To each vial containing 0.5 mL of the Fe(III) solution were added three equivalents (0.06 mL) of the substrate. CD analysis was performed by taking an aliquot (0.05 mL) of the reaction mixture and diluting it further with 2.0 mL of DMSO.
Example 8Quantitative Chiroptical Sensing
(245) ee Determination of Tartaric Acid with FeCl.sub.3.Math.6H.sub.2O
(246) A stock solution of FeCl.sub.3.Math.6H.sub.2O (0.0011 M) in DMSO was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of 19 (0.17 M in water) at varying ee compositions (+100.0, +80.0, +60.0, +40.0, +20.0, 0.0, 20.0, 40.0, 60.0, 80.0, 100.0) and an equimolar amount of TBAOH were prepared. To each vial containing 0.5 mL of the Fe(III) solution were added three equivalents of 19 (0.06 mL). The CD analysis was carried out as described herein at a concentration of 0.5 mM (
(247) Ten scalemic samples of 19 were prepared and then treated with the Fe(III) salt as described herein. Using the linear regression equations obtained from the calibration curves and the measured CD amplitudes at 286 and 338 nm, the enantiomeric excess and the absolute configuration of the major enantiomer were determined (Table 10).
(248) TABLE-US-00010 TABLE 10 Summary of the results obtained by using the regression equations to determine the absolute configuration, and % ee of scalemic samples of tartaric acid using FeCl.sub.36H.sub.2O Sample Chiroptical Sensing Chiroptical Sensing Composition (288 nm) (338 nm) Abs. Actual Abs. Calculated Abs. Calculated Average Config. % ee Config..sup.a % ee.sup.b Config..sup.a % ee.sup.b % ee R, R 88.0 R, R 85.2 R, R 84.8 85.0 R, R 82.0 R, R 80.3 R, R 83.8 82.0 R, R 61.0 R, R 59.0 R, R 59.1 59.1 R, R 46.0 R, R 38.6 R, R 34.5 36.5 R, R 27.0 R, R 22.4 R, R 17.9 20.1 S, S 16.0 S, S 15.3 S, S 12.8 14.1 S, S 33.0 S, S 27.5 S, S 29.7 28.6 S, S 57.0 S, S 66.3 S, S 64.4 65.4 S, S 76.0 S, S 75.3 S, S 72.6 74.0 S, S 94.0 S, S 97.2 S, S 98.5 97.9 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
ee Determination of cis-Aminoindanol with CuCl.sub.2.Math.2H.sub.2O
(249) A stock solution of CuCl.sub.2.Math.2H.sub.2O (0.025 M) in DMSO was prepared and portions of 0.5 mL were transferred into 4 mL vials. Solutions of 25 (0.50 M in DMSO) at varying ee compositions (+100.0, +80.0, +60.0, +40.0, +20.0, 0.0, 20.0, 40.0, 60.0, 80.0, 100.0). To each vial containing 0.5 mL of the Cu(II) solution were added three equivalents of 25 (0.06 mL). The CD analysis was carried out as described herein at a concentration of 0.9 mM (
(250) Five scalemic samples of 25 were prepared and then treated with the Cu(II) salt as described above. Using the linear regression equations obtained from the calibration curves and the measured CD amplitudes at 308 and 382 nm, the enantiomeric excess and the absolute configuration of the major enantiomer were determined (Table 11).
(251) TABLE-US-00011 TABLE 11 ee determination of scalemic samples of of cis-Aminoindanol with CuCl.sub.22H.sub.2O Sample Chiroptical Sensing Chiroptical Sensing Composition (308 nm) (382 nm) Abs. Actual Abs. Calculated Abs. Calculated Average Config. % ee Config..sup.a % ee.sup.b Config..sup.a % ee.sup.b % ee RS 88.0 RS 88.1 RS 87.1 87.6 RS 46.0 RS 48.3 RS 48.2 48.2 SR 16.0 SR 14.2 SR 14.3 14.3 SR 76.0 SR 75.0 SR 73.3 74.2 SR 94.0 SR 95.2 SR 88.6 91.9 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
Example 9Colorimetric Detection
(252) Samples were prepared as described in Example 5. The mixtures (2.0 mM) were stirred for 1 hour at 25 C. and the images were obtained (
Discussion of Examples 5-9
(253) By screening Pd(NO.sub.3).sub.2, FeCl.sub.2, FeCl.sub.3, MnCl.sub.2, CuCl.sub.2, Ce(NO.sub.3).sub.3 and RhCl.sub.3 strong Cotton effects were observed with a broad variety of chiral ligands (
(254) The tested compounds include many examples of amino acids, amino alcohols, hydroxy acids, amines and carboxylic acids. The induced CD (ICD) effects typically have maxima above 300 nm which is advantageous for quantitative ee analysis because interference at lower wavelength arising from small amounts of CD-active impurities can typically be avoided. Importantly, the aliphatic and aromatic test compounds are CD-silent in the absence of the metal salts under the same conditions. Representative CD spectra for the sensing of 1, 10, 23 and 25 using palladium, iron and copper salts are shown in
(255) Based on the distinct CD effects obtained with FeCl.sub.3 and CuCl.sub.2 it was decided to use the simple mix-and-measure protocol described herein for quantitative analysis of the enantiomeric composition of tartaric acid, 19, and cis-aminoindanol, 25. The stoichiometry and structures of ferric and cupric complexes carrying amino acid, hydroxy acid, or amine ligands have been reported based on spectrophotometric, potentiometric and mass spectrometric measurements to vary significantly with solvent, pH and other conditions, and several species can co-exist in solution (Djurdjevic, P. & Jelic, R., Transition Met. Chem. 22:284 (1997); Randhawa, B. S. & Sweety, K., J. Them. Anal. Calorim. 62:295 (2000); Dallavalle et al., Polyhedron 20:103 (2001); Dogan et al., Anal. Biochem. 295:237 (2001); Wu et al., J. Mass Spectrom. 38:386 (2003); Lahsasni et al., Int. J. Electrochem Sci. 7:7699 (2012), which are hereby incorporated by reference in their entirety). It is expected that this is also the case for Fe(III) tartrates and Cu(II) aminoindanol complexes which may form mixtures of mono- and polynuclear species (Timberlake, C. F., J. Chem. Soc. 1229 (1964); Seppala et al., Coord. Chem. Rev. 347:98 (2017), which is hereby incorporated by reference in its entirety). Interestingly, sensing of tartrate with ferric chloride, perchlorate and nitrate salts showed minor differences in the ICD intensities whereas the comparison of the chiroptical signals obtained with cis-aminoindanol and cupric chloride, acetate, trifluoroacetate, nitrate, sulfate and perchlorate revealed more significant counteranion effects on both the ICD shapes and intensities. Altogether, these results indicate that the UV and CD responses observed originate from complex equilibria between co-existing metal complexes. CD titration experiments showed that the addition of (R,R)-19 and (S,R)-25 to FeCl.sub.3 and CuCl.sub.2, respectively, in DMSO yields maximum Cotton effects at a 3:1 ratio. Calibration curves were constructed with nonracemic tartraric acid samples and a linear relationship between the induced CD maxima and the sample ee values was found (
(256) TABLE-US-00012 TABLE 12 Quantitative chirality sensing of tartaric acid samples with FeCl.sub.3. Sample Composition Chiroptical Sensing Results Abs. Abs. % ee (ICDs at Averaged Entry Config. % ee Config..sup.a 288 and 338 nm).sup.b % ee 1 R, R 88.0 R, R 85.2 84.8 85.0 2 R, R 82.0 R, R 80.3 83.8 82.0 3 R, R 61.0 R, R 59.0 59.1 59.1 4 R, R 46.0 R, R 38.6 34.5 36.5 5 R, R 27.0 R, R 22.4 17.9 20.1 6 S, S 16.0 S, S 15.3 12.8 14.1 7 S, S 33.0 S, S 27.5 29.7 28.6 8 S, S 57.0 S, S 66.3 64.4 65.4 9 S, S 76.0 S, S 75.3 72.6 74.0 10 S, S 94.0 S, S 97.2 98.5 97.9 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
(257) Interestingly, the sensing of the amino alcohol 25 with copper(II) chloride in DMSO revealed a nonlinear relationship between the ICD maxima at 308 and 382 nm and the sample cc's (
(258) TABLE-US-00013 TABLE 13 Quantitative chirality sensing of cis- aminoindanol samples with CuCl.sub.2. Sample Composition Chiroptical Sensing Results Abs. Abs. % ee (ICDs at Averaged Entry Config. % ee Config..sup.a 308 and 382 nm).sup.b % ee 1 RS 88.0 RS 88.1 87.1 87.6 2 RS 46.0 RS 48.3 48.2 48.2 3 SR 16.0 SR 14.2 14.3 14.3 4 SR 76.0 SR 75.0 73.3 74.2 5 SR 94.0 SR 95.2 88.6 91.9 .sup.aBased on the sign of the CD response. .sup.bBased on the amplitude of the CD response.
(259) In summary, it is shown herein that optical chirality sensing of unprotected amino acids, hydroxy acids, amino alcohols, amines and carboxylic acids is possible with readily available cobalt, copper, iron, palladium, manganese, cerium or rhodium salts. The broad scope of inexpensive Cu(II) and Fe(III) chlorides that have been successfully applied to chiroptical sensing of a variety of mono and multifunctional compounds is particularly attractive and the ee values of nonracemic samples of tartaric acid and aminoindanol were able to be determine with good accuracy. The mix-and-measure method disclosed herein is very practical, fast and does not require anhydrous solvents or inert reaction conditions. The metal salt and the chiral sample are simply mixed, stirred for one hour and then subjected to CD analysis. A stoichiometric amount of TBAOH is added when acidic compounds are analyzed. The use of a chromophoric ligand or other reagents is not necessary and one can use MeOH, DMSO or water as solvent. The time efficiency, operational simplicity, solvent compatibility and the reduced cost are advantageous features of this optical sensing assay. Additionally, it can be easily adapted to high-throughput experimentation equipment for parallel ee analysis of hundreds of samples.
(260) Although preferred embodiments have been depicted and described in detail herein, it will be apparent to those skilled in the relevant art that various modifications, additions, substitutions, and the like can be made without departing from the spirit of the invention and these are therefore considered to be within the scope of the invention as defined in the claims which follow.